Royal Bank of Canada’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,667
Closed -$222K 6460
2014
Q4
$222K Sell
2,667
-1,653
-38% -$134K ﹤0.01% 4258
2014
Q3
$351K Buy
+4,320
New +$369K ﹤0.01% 3791

Royal Bank of Canada's ALIM Position: Q3 2024 in Review

Royal Bank of Canada sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 2,015 shares — an estimated $11K sold.

Royal Bank of Canada first reported a position in ALIM in Q3 2013 and held it in 15 quarters. The position peaked at $139K in Q4 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Royal Bank of Canada reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 2,015 Alimera Sciences shares in Q3 2024, an estimated $11K.
  • Royal Bank of Canada first reported a position in Alimera Sciences in Q3 2013 and held it in 15 quarters.
  • Royal Bank of Canada's Alimera Sciences position peaked at $139K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.